skip to content
Infectious Disease
Embracing Empathy: Learnings in Developing Accessible STI Testing and Prevention
Immunization Management
Strength in Numbers: Building a Better Vaccine System
Infectious Disease
Reaching the Hardest to Reach: Public Health and the Digital Divide
Infectious Disease
Doing More with Less: Modernizing Approaches to HIV and STI Services in Public Health
COVID-19
Bridging the Gap Between Public and Private Healthcare Delivery: COVID-19 Antiviral Treatment
Infectious Disease
How COVID-19 Prepared Us for MPX: Key Components of Infectious Disease Response Management
Color
Color makes public health happen where public life happens
COVID-19
Understanding the Implications of the OSHA COVID-19 Mandate
COVID-19
COVID-19 Testing and Vaccination Terminology
COVID-19
What to Look for in a COVID-19 Testing and Vaccination Partner
COVID-19
Simple Way to Start a COVID-19 Testing Program for your Team or Organization
Color
Color Announces $167 Million in Series D Financing to Help Build U.S. Public Health Technology and Infrastructure
COVID-19
Color’s Software Facilitating a Significant COVID-19 Testing Increase in California
COVID-19
Antigen Testing vs. PCR-based COVID-19 Testing: Pros & Cons
COVID-19
COVID-19 Testing Industry Consortium formed by 19 United Healthcare Organizations
COVID-19
Color’s COVID-19 Self-Collection Kit Enables Public Health and large Private Labs to Increase Testing Access
COVID-19
Color receives emergency use authorization for unmonitored COVID-19 testing technology
COVID-19
COVID-19 symptoms analysis and clustering methods
COVID-19
New COVID-19 test data: Majority of people who test positive for COVID-19 have mild symptoms or are asymptomatic
